Skip to main content
Jun 07

Amgen

By Uncategorized
Case Study
ALL CASE STUDIES

Bridging Biotech and Device Expertise to Standardize Global Patient Education

Client Snapshot

Industry: Biotech

Stage: Established

Project Type: Patient Education & Cross-Functional Device Support

The Challenge

As a global biotech leader, Amgen supports a vast and diverse portfolio of brands—many of which leverage combination devices and biosimilars. The Patient Strategy Department, a cross-functional initiative within Amgen, needed a scalable, compliant, and patient-centered framework for educating patients across multiple therapeutic areas. Given the complexity of self-injectables, biosimilars, and global regulatory needs, Amgen sought a strategic partner to help unify and elevate their patient education strategy and materials.

Our Approach

LLSS served as agency of record for the Patient Strategy Department, delivering strategic and creative support across patient journey mapping, HFE collaboration, and content development. Our team worked across Amgen’s brand, human factors engineering, and operations functions to co-create a standardized approach to global patient education. We leveraged our unique expertise at the intersection of biotech and device to guide the development of educational assets that are clinically accurate, visually engaging, and usable across international markets.

Solutions Delivered

  • Cross-brand patient journey mapping

  • Global standardization of patient education formats

  • Illustrated materials for combination devices and IFUs

  • Injection logs and tracking tools for self-injectables

  • Demo kits and patient starter packs

  • Co-created educational assets with HFE, operations, and patients

  • Disease state education frameworks

Outcomes & Results

  • Standardized the approach to global patient education across Amgen brands

  • Created reusable, scalable templates for educational content and tools

  • Enabled more consistent collaboration between HFE, brands, and patient cohorts

  • Elevated Amgen’s ability to support biosimilar and combination device launches with patient-centered materials

Feb 19

BD TVA

By Uncategorized

Our Work

ALL CASE STUDIES
Case Study
Go-to-Market Strategy for Healthcare IT Start-up
Looking for Additional Funding
TVA Medical is an early-stage device start-up that developed the first minimally invasive solution for fistula creation for end-stage renal disease patients.

Challenge

After TVA Medical completed its pivotal clinical trials and received CE Mark for its minimally invasive arteriovenous fistula (AVF), it was at a critical juncture needing to secure their next round of funding to garner support from the global clinical community, and to achieve global clearance for everLinQ™ and reimbursement for their endoAVF procedure.

At the same time, the board’s expectations intensified as it scrutinized funding requests and expected larger returns. TVA Medical also needed to create critical momentum within the clinical community to prepare for commercialization and generate awareness to attract suitors for aliquidity event.

Our Solutions

To foster support for this novel technology and procedure, TVA Medical turned to LLSS to develop their medical affairs and global commercialization plans. Given our extensive experience in strategic development and commercial operations, our team of executive-level consultants were ableto immediately plug in to the DNA of TVA Medical to understand its unique challenges.

We created a strategic framework that articulated launch readiness and budget allocation, especially for the board which required clearer context for funding requests. To reassure the board money was being spent wisely we tapped our 125 years of collective leadership experience at life science companies to establish a disciplined spending approach that prioritized when and where investor dollars should be used.

Impressed with our ability to rapidly integrate within their internal teams, TVA Medical asked us to create a playbook for its strategic imperatives. Our team outlined a path to accelerate both clinical community support and clinical trial enrollment by positioning and messaging the core value proposition of the procedure and engaging all
the key stakeholders in the dialysis healthcare ecosystem. Our sales training and support materials helped their internal teams articulate these positions more effectively.

Because of our hybrid business model, our creative specialists were able to provide unparalleled tactical execution of these strategies, including medical illustrations, animations, and HCP/medical education. We developed fresh web content, booth graphics, symposium promotions, and multi-media assets to help generate traffic and lead generation as well as patient education tactics, a clinical onboarding kit, booth graphics and event promotion.

Our streamlined approach to strategy and creative execution not only kept TVA Medical on budget, it provided them with the critical momentum they needed for commercialization.

Our Approach

By working with our team of experts, TVA was able to better articulate their company vision, strategic objectives and tactical plan, giving current and future funders the confidence to invest and thus secured their third round of funding. In addition, the company executed several clinical activities positioning them well for favorable reimbursement and clearance status globally. Since they have rounded out their body of evidence and begun to engage key targets, there is a much stronger interest from the clinical community and “standard of care” is well within reach. The organization has positioned themselves well as a highly attractive prospect for potential M&A activities.

Feb 19

Invetech – old

By Uncategorized

Our Work

ALL CASE STUDIES
Case Study
Global leader of product realization services with a focus on healthcare markets

Challenge

For the last 30 years, Invetech has been a global leader in product design, development, and manufacturing transfer for several industries, including the life sciences industry. In recent years, Invetech began to lose its prominence in its dynamic marketplace. The market was shifting from classic engineering design to a convergence between front-end strategic offerings and traditional product design and development. To maintain a competitive edge in the market, similar firms started partnering with customers earlier in the product lifecycle to help with product ideation and pipeline strategies.

To add to the complexity, Invetech’s marketplace had become more crowded with IoT, ecosystem expansion, and data integration platforms. Invetech needed to showcase its talents as a strategic technology leader in ideation and product planning while still maintaining their coreservice offering.

Our Solutions

Invetech turned to us to regain a competitive edge. With more than 125 years of collective experience inthe life sciences industry, our team was able to quickly plug into their sales and marketing departments and conduct a gap analysis to identify critical success factors and key initiatives for theirrapidly-evolving market.
After developing the strategic plan, we crafted an updated brand position and global messagingplatform to include specific messaging for newtargeted customer segments. The messaging framework emphasized the company’s front-end consulting services complimented by its designand transfer capabilities.

LLSS focus on leveraging Invetech’s strengths of in-house expertise, ideation, usability and business strategy. The true differentiator for the company was their ability to balance all three service deliverables better than any other competitor.

Impressed with our work, executive leadership recommended that this strategic approach should be pulled through to all other divisions company-wide. With Invetech’s growing confidence, they decided to expand our role to lead their sales strategy initiatives as well.

An updated sales enablement deck and new core art elements were developed to support a differentiated concentric design process. A revamped case study template and web redesign highlighted the company’s renewed perspective. The result, Invetech not only recovered lost share, but regained their leadership position.

Our Approach

As a hybrid consulting and creative firm, LLSS has the unique ability to develop tactical plans and the creative supporting tools on budget and on time. This end-to-end plug and play model efficiently guided Invetech through a rebranding initiative, aligning key stakeholders on all aspects of strategy and messaging. Following a thorough analysis of Invetech’s position, a comprehensive execution strategy was put in place to elevate the company’s marketplace position. This approach reduced costs and man-hours during a critical time of the company’s growth.

With LLSS’s comprehensive support, Invetech is now more confident in its marketplace position, offering both front-end consulting services and back-end design-to-manufacturing capabilities for ecosystem-centric designs. The company has regained its reputation as an industry-leader by meeting the needs of the dynamic product design marketplace and is anticipated to surpass its competitors. Inspired by the work LLSS has done, the company’s CEO and executive team now leverage the new messaging and positioning across Invetech’s global parent company.

Note: All trademarks mentioned herein are property of their respective owners.
Feb 19

Philips

By Uncategorized
Case Study
ALL CASE STUDIES

Philips Healthcare, a global leader in intravascular diagnostic imaging and cardiovascular and endovascular therapies

Client Snapshot

Industry: Medical Devices and Healthcare Technology

Stage: Global Enterprise with Recent Acquisition

Project Type: Post-Acquisition Brand Integration and Patient Education Platform Development

The Challenge

Following the acquisition of Volcano Corporation, Philips needed to rapidly integrate an extensive portfolio of vascular intervention products into its corporate brand framework. Beyond brand transition, Philips faced the challenge of educating both healthcare providers and patients about peripheral arterial disease (PAD), a highly underdiagnosed condition. The goal was twofold: standardize product assets under Philips’ global brand and build a multi-tiered education platform to support awareness, diagnosis, and treatment pathways for PAD.

Our Approach

We embedded as the agency of record, leading the full transition of Volcano’s portfolio into Philips’ global brand standards. Working closely with cross-functional Philips teams, we rewrote and restructured content for more than 50 acquired products, ensuring full compliance with Philips’ corporate identity and digital frameworks. Simultaneously, we built a comprehensive disease state education platform — *Take the Step* — designed to drive PAD education across patients, clinicians, and referring physicians. The campaign included a full suite of in-office and at-home patient education materials, sales enablement tools, and marketing assets to extend reach and impact.

Solutions Delivered

  • Transitioned and rebranded over 50 product assets into Philips’ corporate brand standards
  • Developed and launched *Take the Step*, a standalone PAD disease state education platform
  • Created a corporate website section integrating the entire acquired product portfolio
  • Designed comprehensive in-office and take-home patient education materials, including:
    • Symptom checklists and symptom reporting tools
    • Patient discussion guides for physician conversations
    • At-home educational materials for ongoing  disease management
  • Produced a complete sales enablement toolkit featuring:
    • Sales enablement presentations
    • Patient education materials bundled into branded distribution kits
    • Created print and digital assets, including press release templates, newspaper ad   templates, and digital display ad templates
  • Built peer-to-peer education toolkits for healthcare professionals
  • Developed referral education materials targeting primary care and specialty physicians
  • Executed comprehensive conference materials to support field engagement and brand visibility
  • Provided ongoing digital content calendaring for annual conventions and field deployment schedules

Outcomes & Results

  • Successfully transitioned the entire Volcano product line to Philips branding within aggressive acquisition timelines
  • Built a fully integrated PAD patient and HCP education platform adopted across the commercial sales teams
  • Increased awareness and early detection of PAD through multi-channel education initiatives
  • Equipped Philips’ commercial teams with enhanced peer-to-peer and referral engagement tools
  • Expanded Philips’ footprint in the vascular intervention market through stronger physician, referrer, and patient outreach
Close Menu